Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial

Abstract Cyclic high-dose testosterone administration, known as bipolar androgen therapy (BAT), is a treatment strategy for patients with metastatic castration-resistant prostate cancer (mCRPC). Here, we report the results of a multicenter, single arm Phase 2 study (NCT03554317) enrolling 45 patient...

書誌詳細
出版年:	Nature Communications
主要な著者:	Mark C. Markowski, Mary-Ellen Taplin, Rahul Aggarwal, Laura A. Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A. Carducci, Channing J. Paller, Catherine H. Marshall, Mario A. Eisenberger, David E. Sanin, Srinivasan Yegnasubramanian, Carolina Gomes-Alexandre, Busra Ozbek, Tracy Jones, Angelo M. De Marzo, Samuel R. Denmeade, Emmanuel S. Antonarakis
フォーマット:	論文
言語:	英語
出版事項:	Nature Portfolio 2024-01-01
オンライン･アクセス:	https://doi.org/10.1038/s41467-023-44514-2

類似資料

Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss
著者:: Mark C. Markowski, 等
出版事項: (2022-07-01)

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
著者:: Laura A. Sena, 等
出版事項: (2022-12-01)

Corrigendum
著者:: Channing J Paller, 等
出版事項: (2011-03-01)

Therapeutic Approaches to Targeting Androgen Receptor Splice Variants
著者:: Violet A. Daniels, 等
出版事項: (2024-01-01)

Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.
著者:: Mark A Titus, 等
出版事項: (2012-01-01)

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
著者:: Jennifer H. Gunter, 等
出版事項: (2012-01-01)

The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy
著者:: I. G. Rusakov, 等
出版事項: (2020-12-01)

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
著者:: Qin Feng, 等
出版事項: (2019-09-01)

NASP implication in the androgen receptor associated with castration resistance in prostate cancer
著者:: Yun Feng, 等
出版事項: (2025-07-01)

Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.
著者:: Zongwei Wang, 等
出版事項: (2020-01-01)

Castration delays epigenetic aging and feminizes DNA methylation at androgen-regulated loci
著者:: Victoria J Sugrue, 等
出版事項: (2021-07-01)

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression
著者:: Jiayu Chen, 等
出版事項: (2023-12-01)

Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer
著者:: Dena P. Rhinehart, 等
出版事項: (2024-12-01)

New horizons for treating castration resistant prostate cancer: Bipolar Androgen Therapy
著者:: Pedro Henrique Isaacsson Velho, 等
出版事項: (2018-04-01)

Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer
著者:: Tomasz M. Beer, 等
出版事項: (2022-11-01)

Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.
著者:: Xiaotun Zhang, 等
出版事項: (2011-01-01)

Complete androgen blockade safely allows for delay of cytotoxic chemotherapy in castration refractory prostate cancer
著者:: Rafael A. Kaliks, 等
出版事項: (2010-06-01)

Correction: Castration delays epigenetic aging and feminizes DNA methylation at androgen-regulated loci
著者:: Victoria J Sugrue, 等
出版事項: (2023-10-01)

Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond
著者:: Sree M. Lanka, 等
出版事項: (2023-04-01)

Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective
著者:: Jo-Lynn Tan, 等
出版事項: (2017-12-01)

Research Progress on the Mechanism of Androgen Receptor Signaling Pathway in Castration-Resistant Prostate Cancer
著者:: Na Cui, 等
出版事項: (2023-11-01)

CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
著者:: Molishree Joshi, 等
出版事項: (2019-09-01)

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
著者:: Steven Kregel, 等
出版事項: (2013-01-01)

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
著者:: Rosenberg JE, 等
出版事項: (2012-01-01)

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
著者:: Sahyun Pak, 等
出版事項: (2022-09-01)

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
著者:: Balaji Chandrasekaran, 等
出版事項: (2023-03-01)

<sup>177</sup>Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
著者:: Finn E. von Eyben, 等
出版事項: (2021-08-01)

Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.
著者:: John M Kokontis, 等
出版事項: (2014-01-01)

Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer
著者:: Mark C Markowski, 等
出版事項: (2015-01-01)

Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
著者:: Xiaolin Zhu, 等
出版事項: (2024-10-01)

Surgical castration efficiently delays the time of starting a systemic chemotherapy in castration-resistant prostate cancer patients refractory to initial androgen-deprivation therapy
著者:: Minyong Kang, 等
出版事項: (2015-12-01)

Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancer
著者:: Emmanuel S. Akinboye, 等
出版事項: (2019-01-01)

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer
著者:: Shigetomo Yamada, 等
出版事項: (2022-03-01)

Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
著者:: Renliang Yi, 等
出版事項: (2016-01-01)

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
著者:: Bin Gui, 等
出版事項: (2017-01-01)

Effect of Castration Methods on Gene Expression of Androgen Receptor Gene in Skeletal Muscles of Awassi Sheep
著者:: Alaa Kamil Abdulla, 等
出版事項: (2015-12-01)

Therapeutic Potential of Bipolar Androgen Therapy for Castration-Resistant Prostate Cancer: In Vitro and In Vivo Studies
著者:: Jiwoong Yu, 等
出版事項: (2024-01-01)

PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
著者:: Yulu Zhang, 等
出版事項: (2024-07-01)

Effect of Late Androgen Replacement Therapy on Erectile Function Through Structural Changes in Castrated Rats
著者:: Tomoya Kataoka, PhD, 等
出版事項: (2021-08-01)

Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling.
著者:: Holly M Nguyen, 等
出版事項: (2013-01-01)